Sweden: IRRAS raises SKr217m in rights issue

Swedish medtech company IRRAS has raised SKr217m (US$22.3m) in a fully underwritten rights issue to help commercialise its products. Disappointingly, only 56.8% of the offered shares, were subscribed for by exercise of subscription rights. The remainder were picked up by the leads. Carnegie Investment Bank was global coordinator and joint bookrunner together with Pareto Securities….

You must be a HMI Subscriber to view this content.

Subscribe Now »